Company news

Vitasora Health Limited (ASX:VHL) news

Vitasora Health Limited news releases on 6ix. Latest, Oct 5, 2026: Vitasora Market Update Presentation - October 2026

View Vitasora Health Limited →

Press releases & updates

Vitasora Market Update Presentation - October 2026

October 5, 2026

June 2026 Appendix 4E

August 28, 2026

VHL Raises $4m Cornerstoned by $3m Strategic Investment

June 10, 2026

Vitasora Execute vCare Rollout - Revenue Scaling Accelerates

May 17, 2026

Appendix 4D and Half Year Financial Report

February 26, 2026

Appendix 4C and Quarterly Activities Report

January 28, 2026

Completion of A$11m Raise and Cornerstone Investment

January 15, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 31, 2025

Vitasora Expands U.S. Partnership with Evolent

October 23, 2025

Vitasora Cornerstone Investor Placement Update

October 21, 2025

June 2025 Appendix 4E

August 27, 2025

Vitasora unlocks US$4M Medicaid Opportunity

August 12, 2025

Vitasora Raises $11M through Placement

July 1, 2025

Vitasora Capital Raising Presentation

July 1, 2025

Trading Halt

June 29, 2025

Vitasora Secures Value-Based Partnership

June 29, 2025

RSH Provides Update on Supply Chain and US Tariffs

April 8, 2025

Respiri raises $4m through Placement & Proposed Name Change

March 2, 2025

RSH March 2025 Capital Raise Presentation

March 2, 2025

Respiri Enters Partnership with Evolent (NYSE - EVH)

March 2, 2025

Respiri completes acquisition of Orb Health

January 20, 2025

Respiri Signs Binding Purchase Agreement with Orb Health

November 25, 2024

Positive changes to RPM reimbursement criteria

November 4, 2024

Respiri Secures A$1.6 Million Strategic Investment

October 14, 2024

RSH Programs Record Significant Healthcare Cost Reduction

October 3, 2024

RSH secures 1st agreements with Skilled Nursing Facilities

September 22, 2024

Respiri and Ceras Partnership contract with Covenant Health

September 15, 2024

June 2024 Appendix 4E and Preliminary Final Report

August 27, 2024

Respiri Raises $1.1 million Through Additional Placement

July 29, 2024

Respiri raises $3 million through Placement

July 21, 2024

Respiri Raises $1 Million Through Additional Placement

June 4, 2024

May 2024 Investor Presentation

May 8, 2024

Respiri Raises $1.6 million through Additional Placement

April 30, 2024

RSH contracts first Hawaii independent physician association

April 28, 2024

RSH: Cardiovascular AI platform integrated into RPM program

January 24, 2024

EIQ Licenses Software to Respiri - Remote Patient Mon.

January 24, 2024

Reinstatement to Official Quotation

December 13, 2023

$6.5m raised for US expansion, $20m commitment secured

December 13, 2023

Voluntary Suspension

November 30, 2023

Response to ASX Query

November 2, 2023

Further USA Customer Base Growth - ShareCafe Presention

September 29, 2023

Early Redemption of Convertible Note - $1.3m Placement

September 18, 2023

Preliminary Final Report

August 31, 2023

Access secure new $900k annual revenues fr RPM/RTM contracts

August 28, 2023

Respiri completes acquisition of Access Managed Services

August 13, 2023

Completion of private placement

August 11, 2023

SPP strongly supported raising $3m

August 8, 2023

Access Telehealth acquisition presentation

June 6, 2023

RSH acquires US based Access RPM, capital raise and new NED

May 23, 2023

Half Yearly Report and Accounts

February 27, 2023

Older →